Coya Therapeutics, Inc.
COYABiotechnology
$3.61−9.30%As of Oct 30vs prior close
- Market cap
- $84.7M
- P/E (TTM)
- –
- From 52W high
- −44.55%
- EPS (LTM)
- -$1.07
- Revenue (LTM)
- $8M
- Net margin
- -270.22%
- Dividend yield
- 0.00%
Nomior Score
35
Steady ProfileBottom 21% of the scored universe
Growth—
Quality38
Value—
Momentum30
Resilience42
Growth
$8Mrevenue, LTM
YE22 $0LTM $8M
Connections
Revenue to profitQ2 YE26
The operating loss was 2891% of revenue, narrower by 1029 pts on a year.
Who owns it
1fund, 1 tracked portfolio